Freenome, Inc. (FRNM): Total Liabilities
$5.70M
As of 2025-12-31
$7.08M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.70M | +55.8% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $3.66M | n/a | 2026-03-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Freenome, Inc. (FRNM) | 2025-12-31 | $5.70M | +55.8% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $26.52M | +7.1% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| CapForce Inc. (CFOR) | 2025-12-31 | $6.20M | +149.7% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Celcuity Inc. (CELC) | 2025-12-31 | $366.00M | +182.6% |
Compare FRNM, BDSX, SERA, XGN side by side · Screen every company in Services-Medical Laboratories ↗